Discovery of S-777469: An orally available CB2 agonist as an antipruritic agent-Reference-Cited by-同舟云学术

Discovery of S-777469: An orally available CB2 agonist as an antipruritic agent

Published:2012-04 Issue:8 Volume:22 Page:2803-2806
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Odan Masahide,Ishizuka Natsuki,Hiramatsu Yoshiharu,Inagaki Masanao,Hashizume Hiroshi,Fujii Yasuhiko,Mitsumori Susumu,Morioka Yasuhide,Soga Masahiko,Deguchi Masashi,Yasui Kiyoshi,Arimura Akinori

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference11 articles.

1. Cannabinoid receptor localization in brain.

2. Distribution of neuronal cannabinoid receptor in the adult rat brain: A comparative receptor binding radioautography and in situ hybridization histochemistry

3. Molecular characterization of a peripheral receptor for cannabinoids

4. A CB2 receptor agonist, A-836339, modulates wide dynamic range neuronal activity in neuropathic rats: Contributions of spinal and peripheral CB2 receptors

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cannabinoid receptor 2 (CB2) modulators: A patent review (2016–2024);Bioorganic Chemistry;2024-09

2. The Impact of the CB2 Cannabinoid Receptor in Inflammatory Diseases: An Update;Molecules;2024-07-18

3. Modular Approach to Highly Substituted 3-Methylpyridones;The Journal of Organic Chemistry;2024-05-03

4. Cannabinoids and Their Receptors in Skin Diseases;International Journal of Molecular Sciences;2023-11-20

5. Exploring the 1,3-benzoxazine chemotype for cannabinoid receptor 2 as a promising anti-cancer therapeutic;European Journal of Medicinal Chemistry;2023-11